TY  - GEN
AU  - Ansquer,Jean-Claude
AU  - Foucher,Christelle
AU  - Rattier,Stephanie
AU  - Taskinen,Marja-Riitta
AU  - Steiner,George
TI  - Fenofibrate reduces progression to microalbuminuria over 3 years in a placebo-controlled study in type 2 diabetes: results from the Diabetes Atherosclerosis Intervention Study (DAIS)
SN  - 1523-6838
PY  - 2005///1013
KW  - Albuminuria
KW  - epidemiology
KW  - Angiotensin II Type 1 Receptor Blockers
KW  - therapeutic use
KW  - Angiotensin-Converting Enzyme Inhibitors
KW  - Antihypertensive Agents
KW  - Blood Pressure
KW  - Body Mass Index
KW  - Creatinine
KW  - blood
KW  - Diabetes Mellitus, Type 2
KW  - complications
KW  - Diabetic Nephropathies
KW  - Disease Progression
KW  - Double-Blind Method
KW  - Female
KW  - Fenofibrate
KW  - administration & dosage
KW  - Fibrinogen
KW  - analysis
KW  - Follow-Up Studies
KW  - Glycated Hemoglobin
KW  - Homocysteine
KW  - Humans
KW  - Hyperlipidemias
KW  - Hypertension
KW  - Hypolipidemic Agents
KW  - Incidence
KW  - Male
KW  - Middle Aged
KW  - Models, Biological
KW  - Smoking
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1053/j.ajkd.2004.11.004
ER  -